1.
Bladowska J,
Zimny A,
Guzinski M et al.
Usefulness of perfusion weighted magnetic resonance imaging with signal-intensity curves analysis in the differential diagnosis of sellar and parasellar tumors: preliminary report.
Eur J Radiol 2013; 82: 1292-98.
2.
Mahmoud OM,
Tominaga A,
Amatya VJ et al.
Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions.
Eur J Radiol 2010;74(3):420-7.
3.
Chernov MF,
Kawamata T,
Amano K et al.
Possible role of single-voxel 1H-MRS in differential diagnosis of suprasellar tumors.
J Neurooncol 2009;91(2):191-8.
4.
Maia AC,
Malheiros SM,
da Rocha AJ et al.
MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas.
AJNR Am J Neuroradiol 2005;26(4):777-783.
5.
Zateli MCh,
Piccin D,
Vignali C et al.
Pasireotide,
a multiple somatostatin receptor subtypes ligand,
reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.
Endocrine-Related Cancer 2007;14(1):91-102.
6.
Yang S,
Law M,
Zagzag D.
Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas.
AJNR Am J Neuroradiol 2003;24(8):1554-9.
7.
Sartoretti-Schefer S,
Wichmann W,
Aguzzi A,
Valavanis A.
MR differentiation of adamantinous and squamous-papillary craniopharyngiomas.
AJNR Am J Neuroradiol 1997;18(1):77-87.
8.
Holscher T,
Draganski B,
Postert T et al.
Brain perfusion imaging of a craniopharyngioma by transcranial duplex sonography.
J Neuroimaging 2003;13(4):303-6.
9.
Lee IH,
Kim ST,
Kim HJ at al.
Analysis of perfusion weighted image of CNS lymphomas Eur J Radiol 2010; 76: 48-51.
10.
Toh CH,
Wei KC,
Chang CN et al.
Differentiation of Primary Central System Lymphomas and Glioblastomas: Comparisons of Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging without and with Contrast-Leakage Correction AJNR 2013; 34: 1145-49.